Immunotherapy in Nonmelanoma Skin Cancer

被引：4
|
作者：
Bassas Freixas, P. [1 ]
Aparicio Espanol, G. [1 ]
Garcia-Patos Briones, V [1 ]
机构：
[1] Hosp Univ Vail dHebron, Serv Dermatol, Barcelona, Spain
来源：
ACTAS DERMO-SIFILIOGRAFICAS | 2019年 / 110卷 / 05期
关键词：
Nonmelanoma skin cancer; Immunotherapy; Programmed cell death protein 1 (PD-1); Programmed death ligand 1 (PD-L1); Cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4); SQUAMOUS-CELL CARCINOMA; LONG-TERM SURVIVAL; DEATH LIGAND; IPILIMUMAB; EXPRESSION; PEMBROLIZUMAB; REGRESSION; BLOCKADE; CTLA-4; PD-L2;
D O I：
10.1016/j.ad.2018.09.013
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Immunotherapy is emerging as a new and promising treatment for a great variety of tumors, including nonmelanoma skin cancer. Checkpoint inhibitors - antibodies that block proteins that regulate the immune system - mainly target the surface protein CTLA-4 (cytotoxic T-lymphocyte-associated antigen 4) and the PD-1/PD-L1 (programmed cell death protein 1/PD-ligand 1) axis. We review the CTLA-4 and PD-1/PD-L1 pathways and current evidence supporting checkpoint inhibitor therapy in the main types of nonmelanoma skin cancer. (C) 2018 AEDV. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码：353 / 359
页数：7
相关论文
共 50 条
  • [11] Nonmelanoma Skin Cancer
    Kim, Randie H.
    Armstrong, April W.
    DERMATOLOGIC CLINICS, 2012, 30 (01) : 125 - +
  • [12] Prevention of nonmelanoma skin cancer
    Baron, JA
    Greenberg, ER
    ARCHIVES OF DERMATOLOGY, 2000, 136 (02) : 245 - 246
  • [13] Nonmelanoma skin cancer in Canada
    Lynde, C. W.
    Zloty, D.
    Searles, G.
    Claveau, J.
    Barber, K.
    Guenther, L.
    Bourcier, M.
    Sapijaszko, M.
    Vender, R.
    Poulin, Y.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (03) : E60 - E61
  • [14] Hereditary Nonmelanoma Skin Cancer
    Nikolaou, Vasiliki
    Stratigos, Alexander J.
    Tsao, Hensin
    SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2012, 31 (04) : 204 - 210
  • [15] Nonmelanoma skin cancer - Preface
    Schusterman, MA
    CLINICS IN PLASTIC SURGERY, 1997, 24 (04) : R11 - R11
  • [16] Nonmelanoma skin cancer in Australia
    Sinclair, Rodney
    BRITISH JOURNAL OF DERMATOLOGY, 2013, 168 (01) : 1 - 2
  • [17] Nonmelanoma skin cancer in Canada
    Lynde, C. W.
    Zloty, D.
    Searles, G.
    Claveau, J.
    Barber, K.
    Guenther, L.
    Bourcier, M.
    Sapijaszko, M.
    Vender, R.
    Poulin, Y.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 : 48 - 49
  • [18] Treatment of Nonmelanoma Skin Cancer
    Guerrero, Cesar E.
    Elewski, Boni E.
    Elmets, Craig A.
    JAMA INTERNAL MEDICINE, 2013, 173 (22) : 2096 - 2097
  • [19] Diagnosis of nonmelanoma skin cancer
    Brodland, DG
    CLINICS IN DERMATOLOGY, 1995, 13 (06) : 551 - 557
  • [20] NONMELANOMA SKIN-CANCER
    VIRE, CG
    FRUMKIN, A
    EVERETT, MA
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1988, 18 (01) : 133 - 137
12345